Evidence map›Paper›PMID 31578249›Full record

ArticlemSphere2019

Comparative Genomics Reveals a Well-Conserved Intrinsic Resistome in the Emerging Multidrug-Resistant Pathogen Cupriavidus gilardii.

Cristian Ruiz, Ashley McCarley, Manuel Luis Espejo, Kerry K Cooper, Dana E Harmon

Open access · goldAbstract readComparative Study
In one paragraph

Article in mSphere, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Severe pneumonia due toFrontiers in medicine · 2025
    Article
  5. Genomic Sequencing of ClinicalInfection and drug resistance · 2024
    Article
  6. Identification of a novel aminoglycosideFrontiers in microbiology · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. In vitro activity of 20 antibiotics against Cupriavidus clinical strains.The Journal of antimicrobial chemotherapy · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Cristian RuizDepartment of Biology, California State University, Northridge, Northridge, California, USA cristian.ruiz-rueda@csun.edu.ORCID 0000-0003-0039-5180
Ashley McCarleyDepartment of Biology, California State University, Northridge, Northridge, California, USA.
Manuel Luis EspejoDepartment of Biology, California State University, Northridge, Northridge, California, USA.
Kerry K CooperDepartment of Biology, California State University, Northridge, Northridge, California, USA.
Dana E HarmonDepartment of Biology, California State University, Northridge, Northridge, California, USA.
California State University, Northridge · USUniversity of Arizona · US

Funding

BUILD PODER IIRL5GM118975 · NIGMS · CALIFORNIA STATE UNIVERSITY NORTHRIDGE · PI CHAVIRA, GABRIELA, KHACHIKIAN, CRIST SIMON · 2015 to 2023
$10.7M
NIGMS NIH HHS RL5 GM118975
6 · The paper itself

Abstract

The Gram-negative bacterium

Indexed as

Drug Resistance, Multiple, BacterialGenomicsAnti-Bacterial AgentsBacterial ProteinsCupriavidusGenome, BacterialMembrane Transport ProteinsMicrobial Sensitivity TestsPseudomonas aeruginosaAnti-Bacterial AgentsBacterial ProteinsMembrane Transport Proteinsaminoglycosidesantibiotic resistancecarbapenemsCupriavidusCupriavidus gilardii

Identifiers

PMID31578249
PMCPMC6796972
OpenAlexW2978298592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.